Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

Jarding, John, OD

Status and phase: Completed; Phase 2; Phase 1

Conditions: Age-Related Macular Degeneration; Nonexudative Age-related Macular Degeneration

Treatments: Device: Active microcurrent therapy

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT05703867

OL101

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration.

Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.

Enrollment: 404 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults aged at least 50 years with dry AMD in at least one eye

Exclusion criteria

• Eye diseases other than dry AMD
• Implanted electrical devices
• Seizure disorders

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

404 participants in 1 patient group

Active microcurrent therapy

Experimental group

Treatment:

Device: Active microcurrent therapy